Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Cost-effectiveness analysis of the national Perinatal Hepatitis B Prevention Program.

Barbosa C, Smith EA, Hoerger TJ, Fenlon N, Schillie SF, Bradley C, Murphy TV.

Pediatrics. 2014 Feb;133(2):243-53. doi: 10.1542/peds.2013-0718. Epub 2014 Jan 6.

2.

Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection.

Fan L, Owusu-Edusei K Jr, Schillie SF, Murphy TV.

Hepatology. 2016 May;63(5):1471-80. doi: 10.1002/hep.28310. Epub 2015 Dec 23.

PMID:
26509655
3.

The national Perinatal Hepatitis B Prevention Program, 1994-2008.

Smith EA, Jacques-Carroll L, Walker TY, Sirotkin B, Murphy TV.

Pediatrics. 2012 Apr;129(4):609-16. doi: 10.1542/peds.2011-2866. Epub 2012 Mar 26.

PMID:
22451702
4.
5.

Cost-effectiveness of testing hepatitis B-positive pregnant women for hepatitis B e antigen or viral load.

Fan L, Owusu-Edusei K Jr, Schillie SF, Murphy TV.

Obstet Gynecol. 2014 May;123(5):929-37. doi: 10.1097/AOG.0000000000000124.

6.

Cost-effectiveness analysis of prophylactic lamivudine use in preventing vertical transmission of hepatitis B virus infection.

Hung HF, Chen HH.

Pharmacoeconomics. 2011 Dec;29(12):1063-73. doi: 10.2165/11586470-000000000-00000.

PMID:
22077578
7.

Postvaccination serologic testing results for infants aged ≤24 months exposed to hepatitis B virus at birth: United States, 2008-2011.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2012 Sep 28;61:768-71.

9.

Management of infants born to women infected with hepatitis B in the military healthcare system.

Sainato RJ, Simmons EG, Muench DF, Burnett MW, Braun L.

BMC Res Notes. 2013 Aug 28;6:338. doi: 10.1186/1756-0500-6-338.

10.

Cost-effectiveness of maternal treatment to prevent perinatal hepatitis B virus transmission.

Unal ER, Lazenby GB, Lintzenich AE, Simpson KN, Newman R, Goetzl L.

Obstet Gynecol. 2011 Sep;118(3):655-62. doi: 10.1097/AOG.0b013e31822ad2c2.

PMID:
21860297
11.
12.

Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting.

Mansergh G, Haddix AC, Steketee RW, Nieburg PI, Hu DJ, Simonds RJ, Rogers M.

JAMA. 1996 Jul 10;276(2):139-45.

PMID:
8656506
13.

Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention.

Gorsky RD, Farnham PG, Straus WL, Caldwell B, Holtgrave DR, Simonds RJ, Rogers MF, Guinan ME.

Public Health Rep. 1996 Jul-Aug;111(4):335-41.

14.

Antibody response to postexposure prophylaxis in infants born to hepatitis B surface antigen-positive women.

Euler GL, Copeland JR, Rangel MC, Williams WW.

Pediatr Infect Dis J. 2003 Feb;22(2):123-9.

PMID:
12586975
15.

Cost-effectiveness of ensuring hepatitis B protection for previously vaccinated healthcare personnel.

Hoerger TJ, Bradley C, Schillie SF, Reilly M, Murphy TV.

Infect Control Hosp Epidemiol. 2014 Jul;35(7):845-54. doi: 10.1086/676865. Epub 2014 May 29.

PMID:
24915213
16.

Economic evaluation of universal newborn hepatitis B vaccination in China.

Lu SQ, McGhee SM, Xie X, Cheng J, Fielding R.

Vaccine. 2013 Apr 3;31(14):1864-9. doi: 10.1016/j.vaccine.2013.01.020. Epub 2013 Feb 4.

PMID:
23384752
17.

Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.

Margolis HS, Coleman PJ, Brown RE, Mast EE, Sheingold SH, Arevalo JA.

JAMA. 1995 Oct 18;274(15):1201-8.

PMID:
7563509
18.

Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China.

Jia Y, Li L, Cui F, Zhang D, Zhang G, Wang F, Gong X, Zheng H, Wu Z, Miao N, Sun X, Zhang L, Lv J, Yang F.

Hum Vaccin Immunother. 2014;10(10):2983-91. doi: 10.4161/hv.29944.

PMID:
25483678
19.

Prevention of group B streptococcal disease in the first 3 months of life: would routine maternal immunization during pregnancy be cost-effective?

Oster G, Edelsberg J, Hennegan K, Lewin C, Narasimhan V, Slobod K, Edwards MS, Baker CJ.

Vaccine. 2014 Aug 20;32(37):4778-85. doi: 10.1016/j.vaccine.2014.06.003. Epub 2014 Jun 30.

PMID:
24992717

Supplemental Content

Support Center